Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

Plain-English Summary

This bill would make testosterone prescriptions exempt from Rhode Island's prescription drug monitoring program (PDMP). The PDMP is a statewide database that tracks when patients are prescribed and fill certain medications — it's mainly used by doctors, pharmacists, and law enforcement to identify potential drug misuse or overprescribing patterns. Under this bill, pharmacies would no longer be required to report testosterone prescriptions to that database, and any existing testosterone prescription records already in the system would be deleted.

The bill would affect anyone in Rhode Island who has been prescribed testosterone, which includes people receiving hormone therapy for medical conditions, individuals going through gender-affirming hormone treatment, and others with hormonal deficiencies. Currently, those prescriptions are visible within the monitoring system; this bill would remove that visibility entirely and wipe out the historical record of those prescriptions from the database.

Supporters of bills like this often argue that removing testosterone from monitoring databases protects patient privacy, particularly for transgender individuals who may face risks if their medical history is exposed. Those with concerns about such bills may argue that keeping testosterone in the monitoring system helps healthcare providers track prescribing patterns and prevent misuse. The bill was introduced in the Rhode Island House and referred to the House Health & Human Services Committee, which has recommended it be held for further study, meaning it has not moved forward at this time.